What to expect when you take Gilenya and have Haemarthrosis?

Do you take Gilenya and have Haemarthrosis? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 16, 2018

7,657 reports have been studied.


Females aged 50 to 59 :

6,023 related reports were analyzed:

Most common symptoms:

Back pain
  • 5.18% for females aged 50 (±5) who take Gilenya
Chest pain
  • 5.45% for females aged 50 (±5) who take Gilenya
Dizziness
  • 11.47% for females aged 50 (±5) who take Gilenya
Dyspnea (difficult or laboured breathing)
  • 5.56% for females aged 50 (±5) who take Gilenya
Fall
  • 6.11% for females aged 50 (±5) who take Gilenya
Fatigue (feeling of tiredness)
  • 16.35% for females aged 50 (±5) who take Gilenya
Headache (pain in head)
  • 12.75% for females aged 50 (±5) who take Gilenya
Heart rate decreased
  • 5.73% for females aged 50 (±5) who take Gilenya
High blood pressure
  • 5.61% for females aged 50 (±5) who take Gilenya
Malaise (a feeling of general discomfort or uneasiness)
  • 5.08% for females aged 50 (±5) who take Gilenya
Nausea (feeling of having an urge to vomit)
  • 7.62% for females aged 50 (±5) who take Gilenya
Weakness
  • 8.14% for females aged 50 (±5) who take Gilenya
White blood cell count decreased
  • 5.5% for females aged 50 (±5) who take Gilenya

Most common co-existing conditions:

  • n/a
back to top

Males aged 50 to 59 :

1,634 related reports were analyzed:

Most common symptoms:

Chest pain
  • 5.45% for males aged 50 (±5) who take Gilenya
Dizziness
  • 8.94% for males aged 50 (±5) who take Gilenya
Fatigue (feeling of tiredness)
  • 14.38% for males aged 50 (±5) who take Gilenya
Gait disturbance
  • 6.79% for males aged 50 (±5) who take Gilenya
Headache (pain in head)
  • 9.12% for males aged 50 (±5) who take Gilenya
Heart rate decreased
  • 5.75% for males aged 50 (±5) who take Gilenya
High blood pressure
  • 5.63% for males aged 50 (±5) who take Gilenya
Lymphocyte count decreased
  • 6.12% for males aged 50 (±5) who take Gilenya
Malaise (a feeling of general discomfort or uneasiness)
  • 5.51% for males aged 50 (±5) who take Gilenya
Nausea (feeling of having an urge to vomit)
  • 5.08% for males aged 50 (±5) who take Gilenya
Vision blurred
  • 5.39% for males aged 50 (±5) who take Gilenya
Weakness
  • 9.06% for males aged 50 (±5) who take Gilenya

Most common co-existing conditions:

  • n/a
back to top

Related studies

gilenya

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. (latest outcomes from Gilenya 47,324 users)

haemarthrosis

Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule) has been reported by people with factor viii deficiency, atrial fibrillation/flutter, preventive health care, haemophilia, stroke (latest reports from 2,551 Haemarthrosis patients).

Gilenya and Haemarthrosis

Related publications that referenced our studies


Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Gilenya, Haemarthrosis

Recent updates

General studies
Active Support Groups
Recent Care Guides

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.